Company · CIK 0001903784 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Vogenx, Inc. · VOGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 CForm 4 → | Aug 13, 4:45 pm EDT | Peter PieracciniDirector | 42,735 | $11.70 | $499,999 | 42,735 | — | |
| Aug 13, 2026 CForm 4 → | Aug 13, 4:43 pm EDT | Steven R DelmarChief Financial Officer, Director | 4,273 | $11.70 | $49,994 | 704,273 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 CForm 4 → | Aug 13, 4:45 pm EDT | Peter PieracciniDirector | — | — | — | 0 | — | |
| Aug 13, 2026 CForm 4 → | Aug 13, 4:43 pm EDT | Steven R DelmarChief Financial Officer, Director | — | — | — | 0 | — |